| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.09 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |